USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
06-Jun-2018
Global
Market Research
MDB6-01-00-00-00
HC03018-NA-MR_21980
Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of treatment in cases of CHF, hypertension, and diabetes, obesity treatment requires a mixture of nutritional, behavioral, and drug therapies, wherein drugs act as an adjunct to the behavioral therapies.
With the growing number of cardiometabolic cases worldwide, the market is slowly shifting toward ‘Therapy-as-a-Service’ model, with the implementation of adjunct therapies such as digital therapeutics, AI-based predictive diagnostic tools as well as nutritional and behavioral therapies alongside traditional drug treatment. This has helped establish a comprehensive care continuum across the industry, with wellness programs playing an important role in disease diagnosis, treatment, and monitoring.
Research Scope
The present study aims at identifying some of the key growth opportunities, which are set to drive the market in the next few years. Additionally, the study also identifies the most prevalent and emerging business models across the market, which are supporting industry stakeholders in enhancing their geographic coverage in terms of patient outreach and address challenges of inadequate patient access. The study provides in-depth revenue and market analysis of 4 key markets, chronic heart failure (CHF), hypertension, diabetes, and obesity. The study also highlights some of the key market drivers and restraints that affect the growth. It gives an overview of the competitive environment providing brief insights on some of the game-changing participants across each segment that are working toward developing disruptive technologies and drugs, thus maintaining their growth trajectory. Focus is also given on some of the leading M&A activities impacting the market as well as present and future market trends that would shape the market.
Key Issues Addressed
- How is the market attractiveness for cardiometabolic therapeutics evolving over the years? What is the future market potential?
- What is the role played by primary and community care in management of cardiometabolic diseases?
- What are the current and future trends impacting the market growth? What are the emerging business models set to transform the market landscape?
- What are the key regulatory and pricing changes across the cardiometabolic market? How are these changes expected to affect the market in the long run?
- What are the major growth opportunities across the cardiometabolic diseases market? What kind of impact would these have on the market growth?
- What are the applications of emerging technologies and digital transformation on the overall market? How is it expected to impact the market in the next few years?
Key Findings
Key Findings (continued)
Scope and Segmentation
Key Questions to be Answered
Market Engineering Measurements
Market Engineering Measurements (continued)
Market Engineering Measurements (continued)
Market Engineering Measurements (continued)
CEO’s Perspective
Big Market Themes
Executive Summary—3 Big Predictions
Market Segmentation
Key Trends and Impact on the Market
Cardiometabolic Diseases—Value Chain Analysis
Impact of Regulatory and Pricing Policies
VBP Models—Impact Analysis
Disruptive Market Participants
New Market Opportunities
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Market Summary
Methodology and Forecast Assumptions
Revenue Forecast by Segment
Revenue Forecast Discussion
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Future Trends for Cardiometabolic Diseases Market
Transformation in Cardiometabolic Industry Ecosystem—2017
5 Major Growth Opportunities
Growth Opportunity Impact Analysis
Growth Opportunity 1—Enhanced Patient Engagement Through Digital Therapeutics
Growth Opportunity 2—Clinical Support leveraged Through AI
Growth Opportunity 3—Innovative Drug Delivery Technologies for Better Drug Efficacy
Growth Opportunity 4—Regenerative Medicine for Novel Curative Therapies
Growth Opportunity 5—Leveraging Biomarkers for Risk Assessment and Disease Diagnosis
Strategic Imperatives for Success and Growth
3 Big Predictions
Legal Disclaimer
Cardiometabolic Health Congress (CMHC)
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Abbreviations
Market Engineering Methodology
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
The present study aims at identifying some of the key growth opportunities, which are set to drive the market in the next few years. Additionally, the study also identifies the most prevalent and emerging business models across the market, which are supporting industry stakeholders in enhancing their geographic coverage in terms of patient outreach and address challenges of inadequate patient access. The study provides in-depth revenue and market analysis of 4 key markets, chronic heart failure (CHF), hypertension, diabetes, and obesity. The study also highlights some of the key market drivers and restraints that affect the growth. It gives an overview of the competitive environment providing brief insights on some of the game-changing participants across each segment that are working toward developing disruptive technologies and drugs, thus maintaining their growth trajectory.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aarti Chitale |
| Industries | Healthcare |
| WIP Number | MDB6-01-00-00-00 |
| Keyword 1 | Cardiometabolic |
| Is Prebook | No |
| GPS Codes | 9600-B1,9611-B1 |
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
$4,950.00
Special Price $3,712.50 save 25 %